Polymorphisms and haplotypes in candidate genes related to angiogenesis and endothelial dysfunction in preeclampsia

Journal of Pregnancy

Volumn 2012, Issue , 2012, Pages

  Luizon, Marcelo Rizzatti ^a   Palei, Ana Carolina Taveiros ^b   Sandrim, Valeria Cristina ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Nucleo de Pos Graduacao e Pesquisa   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

FEMALE; GENETIC MARKER; GENETICS; HAPLOTYPE; HUMAN; LETTER; PREECLAMPSIA; PREGNANCY; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC MARKERS; HAPLOTYPES; HUMANS; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866233034     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2012/914704     Document Type: Review

References (11)

1. Valenzuela F. J., Perez-Sepulveda A., Torres M. J., Correa P., Repetto G. M., Illanes S. E., Pathogenesis of preeclampsia: the genetic component. Journal of Pregnancy 2012 2012 8 632732 10.1155/2012/632732
2. Sandrim V. C., Palei A. C. T., Cavalli R. C., Araújo F. M., Ramos E. S., Duarte G., Tanus-Santos J. E., Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Molecular Human Reproduction 2009 15 2 115 120 2-s2.0-60149095533 10.1093/molehr/gan076
3. Luizon M. R., luizonmr@usp.br Sandrim V. C., Importance of haplotype analysis in association studies considering VEGF promoter polymorphisms. Clinical Biochemistry 2011 44 8-9 747 10.1016/j.clinbiochem.2011.02.015
4. Muniz J. J., Izidoro-Toledo T. C., Metzger I. F., Sandrim V. C., Tanus-Santos J. E., Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms. DNA and Cell Biology 2009 28 11 567 572 2-s2.0-70350452566 10.1089/dna.2009.0925
5. Sandrim V. C., Palei A. C. T., Cavalli R. C., Araújo F. M., Ramos E. S., Duarte G., Tanus-Santos J. E., eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 2008 9 10 1467 1473 2-s2.0-55449090921 10.2217/14622416.9.10.1467
6. Sandrim V. C., Palei A. C. T., Luizon M. R., Izidoro-Toledo T. C., Cavalli R. C., Tanus-Santos J. E., ENOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. The Pharmacogenomics Journal 2010 10 1 40 45 2-s2.0-75549085532 10.1038/tpj.2009.38
7. Sandrim V. C., Palei A. C. T., Sertorio J. T., Cavalli R. C., Duarte G., Tanus-Santos J. E., Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Molecular Human Reproduction 2010 16 7 506 510 2-s2.0-77954183977 10.1093/molehr/gaq030
8. Palei A. C. T., Sandrim V. C., Amaral L. M., Machado J. S. R., Cavalli R. C., Lacchini R., Duarte G., Tanus-Santos J. E., Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal. In press 10.1038/tpj.2011.31
9. Palei A. C. T., Sandrim V. C., Duarte G., Cavalli R. C., Gerlach R. F., Tanus-Santos J. E., Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension. Clinica Chimica Acta 2010 411 11-12 874 877 2-s2.0-77949551053 10.1016/j.cca.2010.03.002
10. Luizon M. R., Sandrim V. C., Palei A. C., Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy. Submitted to: Hypertension Research
11. Hutcheon J. A., jhutcheon@cfri.ca Lisonkova S., Joseph K. S., Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Practice and Research 2011 25 4 391 403 10.1016/j.bpobgyn.2011.01.006